World Health Day: Late diagnosis, rising lifestyle diseases put young India at risk
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
Health of the Nation 2026, based on over 3 million assessments, finds rising diabetes, obesity, and hidden cardiac risks in under-30s and working professionals
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
HYMPAVZI is already approved in the US for patients 12 and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors
Currently approved for patients eight and older, Tzield could now be used to delay the onset of stage 3 type 1 diabetes (T1D) in children diagnosed with stage 2 T1D
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
Researchers from Bar-Ilan University find that even in old age, feeling young can lower the risks of developing physical disability and morbidity
Submission to regulators globally is based on phase 2/3 studies of mRNA-1273 in young children
For over a decade, AstraZeneca and Plan India’s Young Health Program have been generating awareness and identifying sustainable solutions to influence the behaviour of youths against Non-Communicable Diseases
Subscribe To Our Newsletter & Stay Updated